摘要:
Reactive carriers are described that can be used with dispersants and pigments in inks and coatings. The reactive carriers have at least two sets of carbon to carbon double bond that are generally reactive in alkyd type drying reactions. The substitution of reactive carriers for solvents in an ink or coating can reduce the volatile organic content of a formulated ink or coating.
摘要:
The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
摘要:
A process for preparing conjugated linoleic acid (CLA) or derivatives thereof from ricinoleic acid, lower alkyl esters of ricinoleic acid, or salts thereof. The CLA is formed by reacting a carboxylic acid, or anhydride, anhydride equivalent, or ester thereof with the ricinoleic acid or derivative to form an intermediate having a carboxylic ester at the 12-hydroxy position of the ricinoleic acid or derivative, and reacting the intermediate with a base to form a cis-9, trans-11 conjugated linoleic acid.
摘要:
Disclosed are compounds comprising a benzenediol derivative bound to one or more fatty acids. Also disclosed are nutritional supplements, pharmaceutical formulations, delivery devices, and foodstuffs comprising the disclosed compounds. Methods of using the disclosed compounds and compositions to improve health are also disclosed.
摘要:
A compound of formula (I), wherein one of R 1 and R 2 is a methyl group and the other of R 1 and R 2 is a hydrogen atom; wherein X represents a carboxylic acid group, a carboxylate group, or a carboxamide group; or any pharmaceutically acceptable salt, solvate, complex or pro-drug thereof, for use as a medicament, is disclosed. A pharmaceutical composition and a fatty acid composition comprising a compound of formula (I) is also disclosed. The use of a compound of formula (I) for the manufacture of a medicament, in particular for the treatment of diabetes type 2, is also disclosed.
摘要:
Compounds of formula (I); wherein - R 1 and R 2 are the same or different and may be selected from the group consisting of a hydrogen atom, a hydroxy group, an alkyl group, a halogen atom, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an alkynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, an alkylsulfmyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; and - X represents a carboxylic acid group, a carboxylate group, or a carboxamide group; or any pharmaceutically acceptable salt, solvate, complex or pro-drug thereof, with the provisos that the compound of formula (I) is not (all-Z)-4,7,10,13,16,19- docosahexaenoic acid (DHA), alpha-methyl DHA, alpha-methyl DHA methyl ester, alpha-methyl DHA ethyl ester or alpha-hydroxy DHA ethyl ester, are disclosed. A fatty acid composition and a pharmaceutical composition comprising such compounds are also disclosed. The use of such compounds as medicaments, in particular for the treatment of diabetes type 2, is also disclosed.
摘要:
The invention refers to a process for obtaining fatty acid alkyl esters, rosin acids and sterols from crude tall oil (CTO), which is characterised by the following steps: (a) reacting the free fatty acids present in the CTO with lower alcohols; (b) esterifying the sterols in the CTO with boric acid or transesteriying with catalyst; (c) separating the fatty acid lower alkyl esters and rosin acids from 10 the remaining sterol borate esters or sterol esters of fatty acids to produce a stream of sterol esters; (d) separating the fatty acid alkyl esters from the rosin acids to produce a first stream of fatty acid alky esters and a second stream of rosin acids; and (e) converting said sterol esters into the free sterols to produce a third stream of free sterols.
摘要:
La presente invención se refiere al uso de compuestos fenólicos y sus derivados que están representados por la fórmula I, donde R1 y R2 se seleccionan de entre: OH, OCOalquilo, o OCOalquenilo, y R3 es bien H, OH, OCOalquilo o OCOalquenilo, donde las cadenas alquílicas o alquenílicas presentan de 2 a 22 átomos de carbono y donde al menos un grupo OCOalquilo o OCOalquenilo está presente en la estructura, para la prevención y el tratamiento de enfermedades cardiovasculares, hepáticas y renales, así como a sus aplicaciones cosméticas, a composiciones que incluyen estos compuestos y a algunos compuestos fenólicos y derivados que son nuevos.
摘要:
The invention relates to a novel extraction method for obtaining at least one unsaturated, optionally derivatised compound, from mixtures of said compounds with other less saturated constituents, e.g. for obtaining polyunsaturated fatty acids or the derivatives thereof from mixtures with saturated and/or less unsaturated, optionally derivatised fatty acids, by means of selective complexation with a cation exchanger which is partially or fully charged with silver ions, and subsequent decomplexation.